If you are an establishment that manufactures an HCT/P that does not meet the criteria set out in § 1271.10(a) , and you do not qualify for any of the exceptions in § 1271.15 , your HCT/P will be regulated as a drug, device, and/or biological product under the act and/or section 351 of the PHS Act, and applicable regulations in title 21, chapter I. Applicable regulations include, but are not limited to, §§ 207.9(a)(5) , 210.1(c) , 210.2 , 211.1(b) , 807.20(d) , and 820.1(a) of this chapter , which require you to follow the procedures in subparts C and D of this part .
21 CFR Part 1271 · Human Cells, Tissues, and Cellular and Tissue-Based Products
§ 1271.20 If my HCT/P's do not meet the criteria in § 1271.10, and I do not qualify for any of the exceptions in § 1271.15, what regulations apply?
Independent copy, not an official legal edition. 21 CFR is a U.S. Government work in the public domain; this text comes from the eCFR and the annual CFR edition, and may lag recent amendments. The authoritative version is on ecfr.gov. Compliome is not affiliated with or endorsed by FDA. Not legal advice.
Warning letters citing § 1271.20
17 FDA warning letters since 2017 cite this section ; the most recent:
- Calibrate IV Hydration 13 Oct 2026
- Beaute Bounty 25 Sept 2026
- NexCell Scientific Inc 11 Sept 2026
- R3 Medical Companies 14 Aug 2026
- Blue Horizon International, LLC 26 May 2026
- Dynamic Stem Cell Therapy 11 Feb 2026
- Microvascular Tissue, Inc. 3 Dec 2025
- BioXtek LLC 1 Dec 2025
- New Life Medical Services, LLC 24 Sept 2025
- NuVida Medical LLC 4 Sept 2025
- Platinum Biologics LLC 15 Aug 2025
- Innate Healthcare Institute 15 Aug 2025
FDA guidance that cites § 1271.20
- Regulation of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) - Small Entity Compliance Guide: Guidance for Industry 1 Nov 2022
- Current Good Manufacturing Practice Requirements for Combination Products: Guidance for Industry and FDA Staff 11 Jan 2017
- Current Good Tissue Practice (CGTP) and Additional Requirements for Manufacturers of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps): Guidance for Industry 1 Dec 2011
- Certain Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) Recovered from Donors Who Were Tested for Communicable Diseases Using Pooled Specimens or Diagnostic Tests: Guidance for Industry 16 Apr 2008
Amendment history
Federal Register documents that created or amended this section.
- 66 FR 5466 19 Jan 2001
- 81 FR 60223 31 Aug 2016